08/28/2024 3:31 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 12:16 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024 10:35 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/26/2024 3:38 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/25/2024 3:04 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 9:54 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2024 4:35 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/17/2024 4:14 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/15/2024 3:38 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024 3:28 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024 3:30 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2024 9:28 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024 5:04 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/05/2024 3:10 PM | Crinetics Pharmaceuticals (Subject) Hassard James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024 12:07 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/02/2024 3:32 PM | Crinetics Pharmaceuticals (Issuer) Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2024 4:31 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:32 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:03 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 10:01 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 5:07 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024 4:08 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2024 4:24 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 3:45 PM | Crinetics Pharmaceuticals (Filer)
| Form S-3ASR | |
06/21/2024 3:31 PM | Crinetics Pharmaceuticals (Subject) Hassard James (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024 3:35 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:30 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/10/2024 10:55 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/28/2024 12:44 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024 7:23 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 5:29 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/25/2024 3:47 PM | Crinetics Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024 3:48 PM | Crinetics Pharmaceuticals (Filer)
| Form DEFA14A | |
04/25/2024 3:50 PM | Crinetics Pharmaceuticals (Filer)
| Form ARS | |
04/22/2024 4:23 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/17/2024 3:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2024 4:09 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2024 3:52 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9244&Placement=NativeDisplay&Source=NativeDisplay) One company holds a near-total monopoly on it. |
04/04/2024 3:17 PM | Crinetics Pharmaceuticals (Subject) Struthers Richard Scott (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/26/2024 3:30 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 3:31 PM | Crinetics Pharmaceuticals (Issuer) Fust Matthew K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 1:34 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024 4:20 PM | Crinetics Pharmaceuticals (Subject) Knight Jeff E. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 5:31 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:32 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:33 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:34 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:35 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 5:36 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:37 PM | Crinetics Pharmaceuticals (Subject) Fust Matthew K (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:40 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 5:31 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2024 3:15 PM | Crinetics Pharmaceuticals (Filer)
| Form D Notice of Exempt Offering of Securities | |
03/11/2024 2:34 PM | Crinetics Pharmaceuticals (Subject) EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
03/06/2024 7:18 PM | Crinetics Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:59 PM | Crinetics Pharmaceuticals (Issuer) Knight Jeff E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:00 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 7:01 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 6:57 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:05 PM | Crinetics Pharmaceuticals (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13D/A | |
03/01/2024 3:41 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 POS | |
02/28/2024 3:31 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024 5:36 PM | Crinetics Pharmaceuticals (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024 6:54 AM | Crinetics Pharmaceuticals (Subject) DRIEHAUS CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:50 AM | Crinetics Pharmaceuticals (Subject) FMR LLC (Filed by)
| Form SC 13G | |
01/26/2024 4:50 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/24/2024 9:28 AM | Crinetics Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
01/12/2024 3:12 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 11:10 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 7:03 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/04/2024 3:43 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2024 3:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2024 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/27/2023 4:20 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/26/2023 10:47 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 5:45 PM | Crinetics Pharmaceuticals (Issuer) Pizzuti Dana (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/21/2023 4:28 PM | Crinetics Pharmaceuticals (Subject) Pizzuti Dana (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/14/2023 3:37 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 3:44 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:35 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 12:48 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2023 3:31 PM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 10:40 AM | Betz Stephen F. (Reporting) Crinetics Pharmaceuticals (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023 3:33 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/07/2023 3:31 PM | Crinetics Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/06/2023 5:02 PM | Crinetics Pharmaceuticals (Issuer) Struthers Richard Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/03/2023 6:38 PM | Crinetics Pharmaceuticals (Issuer) Wilson Marc (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post.
With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.![](https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx?TriggeredCampaignID=9460&Placement=NativeDisplay&Source=NativeDisplay) Learn more about this much-needed advancement and investment opportunity here. |
11/01/2023 3:44 PM | Crinetics Pharmaceuticals (Subject) Wilson Marc (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023 4:01 PM | Crinetics Pharmaceuticals (Issuer) Krasner Alan Seth (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2023 3:20 PM | Crinetics Pharmaceuticals (Subject) Krasner Alan Seth (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:24 PM | Crinetics Pharmaceuticals (Subject) Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
09/13/2023 4:19 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/13/2023 4:23 PM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:09 PM | Crinetics Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2023 5:05 AM | Crinetics Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |